These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8587412)

  • 1. Regional variations in ETA/ETB binding sites in human coronary vasculature.
    Dashwood MR; Timm M; Kaski JC
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S351-4. PubMed ID: 8587412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of endothelin receptors in atherosclerotic human coronary arteries.
    Bacon CR; Cary NR; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S439-41. PubMed ID: 8587438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETA receptors predominate in the human vasculature and mediate constriction.
    Davenport AP; Kuc RE; Maguire JJ; Harland SP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S265-7. PubMed ID: 8587384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelin receptors in benign human tumours of uterine muscle].
    Breuiller-Fouché M; Honoré JC; Robert B; Fournier T; Vacher-Lavenu MC; Chapron C; Dubuisson JB; Ferré F
    Bull Cancer; 1999 Sep; 86(9):773-8. PubMed ID: 10519970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype?
    Hay DW; Luttmann MA; Pullen MA; Nambi P
    J Pharmacol Exp Ther; 1998 Feb; 284(2):669-77. PubMed ID: 9454813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of peptide and nonpeptide antagonists in human kidney.
    Kuc RE; Karet FE; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S373-5. PubMed ID: 8587419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin receptors in human coronary artery and aorta.
    Bacon CR; Davenport AP
    Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans.
    Haynes WG; Strachan FE; Gray GA; Webb DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S40-3. PubMed ID: 8587426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors.
    Maguire JJ; Bacon CR; Fujimoto M; Davenport AP
    J Hypertens; 1994 Jun; 12(6):675-80. PubMed ID: 7963492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
    Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of endothelin-1 mRNA expression and immunoreactivity in the anterior segment of human eye: expression of ETA and ETB receptors.
    Fernández-Durango R; Rollín R; Mediero A; Roldán-Pallares M; García Feijo J; García Sánchez J; Fernández-Cruz A; Rípodas A
    Mol Vis; 2003 Apr; 9():103-9. PubMed ID: 12692512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit.
    Maurice MC; Gratton JP; D'Orléans-Juste P
    Br J Pharmacol; 1997 Jan; 120(2):319-25. PubMed ID: 9117126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of BQ-485, a selective ETA antagonist, on endothelin-mediated vasomotion in rat coronary vascular beds.
    Sakuma I; Asajima H; Fukao M; Tohse N; Tamura M; Kitabatake A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S400-3. PubMed ID: 8587427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139.
    Russell FD; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S346-7. PubMed ID: 8587410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptors in lower esophageal sphincter circular smooth muscle.
    Huang SC
    Regul Pept; 2005 Apr; 127(1-3):27-35. PubMed ID: 15680467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression.
    Sutherland AJ; Nataatmadja MI; Walker PJ; Cuttle L; Garlick RB; West MJ
    Circulation; 2006 Mar; 113(9):1180-8. PubMed ID: 16505174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial effects of ETB receptor stimulation.
    Leite-Moreira AF; Brás-Silva C; Pedrosa C
    Rev Port Cardiol; 2002 Sep; 21(9):1009-16. PubMed ID: 12416272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin receptor subtypes and their functional relevance in human small coronary arteries.
    Pierre LN; Davenport AP
    Br J Pharmacol; 1998 Jun; 124(3):499-506. PubMed ID: 9647474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between endothelin receptors and chronic venous insufficiency of lower extremities].
    Yang L; Qi GY; Cao YX; Liu J; Zhao M
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1325-8. PubMed ID: 19094564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable expression of human endothelin receptors ETA and ETB by transfected baby hamster kidney cells.
    Hechler U; Becker A; Haendler B; Schleuning WD
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1305-10. PubMed ID: 8352789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.